Upper tract urothelial carcinoma (UTUC) is an aggressive disease that is challenging to biopsy and diagnose, frequently yielding nondiagnostic cytology and tissue specimens. Therefore, UTUC is often ...

molecular and genetic studies indicate differences in the biologic mechanisms underlying upper-tract and bladder urothelial carcinoma Bladder cancer occurs in 15 50% of patients following upper ...

Discover a study that revealed that patients receiving induction chemotherapy before radical nephroureterectomy experienced ...

Accurately diagnosing and staging patients with upper tract urothelial carcinoma (UTUC) has proven challenging for clinicians. Experts at Memorial Sloan Kettering recently applied genomic ...

Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva.

One of its most peculiar characteristics is a strong association with upper urothelial cancer (UUC). BEN-related UUC has the same histological features as other forms of UUC in general ...

Among management options for node-positive upper tract urothelial cancer (UTUC), induction chemotherapy added to radical nephroureterectomy (RNU) provides the best cancer control and survival outcomes ...

30-33 However, it should be noted that a more challenging disease setting where utDNA testing may prove particularly helpful is in upper tract urothelial cancer. 36,37 Still, despite the improved ...

In parallel, UroGen's FDA-approved treatment, JELMYTO, has demonstrated sustained effectiveness in treating low-grade upper tract urothelial cancer, with a median duration of response of 47.8 ...

SAN DIEGO, Calif. (Ivanhoe Newswire) - Rare cancers are considered cancers that affect fewer than 40,000 people per year. But when you put them all together, they make up more than a quarter of ...

The company’s products, all branded Cxbladder, are a new class of bladder cancer detection and management tests that detect urothelial cancers including those in the upper urinary tract and ...

molecular and genetic studies indicate differences in the biologic mechanisms underlying upper-tract and bladder urothelial carcinoma Bladder cancer occurs in 15 50% of patients following upper ...